[HTML][HTML] Peptide-Bound Glycative, AGE and Oxidative Modifications as Biomarkers for the Diagnosis of Alzheimer's Disease—A Feasibility Study
Background: The diagnosis of Alzheimer's disease (AD) relies on core cerebrospinal fluid
(CSF) biomarkers, amyloid beta (Aβ) and tau. As the brain is then already damaged …
(CSF) biomarkers, amyloid beta (Aβ) and tau. As the brain is then already damaged …